Ticker Launch

SPAC · Merger completed

LifeSci Acquisition Corp.

Business combination with Vincera Pharma, Inc.

LifeSci Acquisition Corp. is a blank-check company (SPAC) that raised $60M in its initial public offering on Mar 9, 2020, listing on Nasdaq Capital Market. It completed its business combination with Vincera Pharma, Inc. on Dec 23, 2020; the combined company is Vincera Pharma, Inc. (now Vincerx Pharma) (VINC). Loeb & Loeb advised the SPAC and Kirkland & Ellis advised the underwriters on the IPO.

Vincera Pharma is a recently formed clinical-stage life sciences company focused on developing new therapies for cancer. It intends to develop multiple products through clinical proof-of-concept and potentially through Accelerated Approval in the United States.

Status
Merger completed
IPO date
Mar 9, 2020
IPO size
$60M
IPO exchange
Nasdaq Capital Market
Target
Vincera Pharma, Inc. (VNRX Corp.)
Announced
Sep 29, 2020
Closed
Dec 23, 2020
Combined company
Vincera Pharma, Inc. (now Vincerx Pharma) (VINC)
SPAC counsel (IPO)
Loeb & Loeb
Underwriters' counsel (IPO)
Kirkland & Ellis

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2020